http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109824801-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G83-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03C17-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
filingDate 2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109824801-B
titleOfInvention Synthesis method of cyclodextrin modified dopamine derivative
abstract The invention discloses a synthesis method of a cyclodextrin modified dopamine derivative, which comprises the steps of mixing mono-6-p-toluenesulfonyl cyclodextrin with dopamine hydrochloride according to a molar ratio of 1: 5-10, adding 4-dimethylaminopyridine and potassium iodide as catalysts, and vacuumizing to enable a reaction system to reach an anhydrous and anaerobic state; and respectively adding anhydrous N, N-dimethylformamide and anhydrous methanol, stirring, dissolving a solid sample, adjusting the pH value to weak acidity, reacting at 80-100 ℃ for 12-24 hours to obtain a reaction mixed solution, performing rotary evaporation to volatilize the solvent, and performing column chromatography elution to obtain the mono-6-deoxy-dopamine cyclodextrin derivative. The cyclodextrin modified dopamine derivative synthesized by the invention reduces the problem of uneven settlement of polydopamine on the surface of the material, has excellent performance of realizing degradability in a living body, and overcomes the defects that an oil-soluble drug material is difficult to combine with hydrophilic polydopamine and the fixation and sustained release of the drug are difficult to realize.
priorityDate 2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414927286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411660655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457193618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892

Total number of triples: 44.